Paysign remains a buy, supported by strong performance in both Plasma Centers and hypergrowth in Patient Affordability. Learn ...
Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...
Introduction Myoglobin (Mb) exerts both direct and indirect nephrotoxic effects, contributing to the progression of kidney injury. For patients with rhabdomyolysis (RM) and acute kidney injury (AKI) ...
Plasmalogens are essential lipids made by the body to build and maintain biological membranes and neutralize oxidative stress. They are found in high concentrations in the brain, heart, lung, kidney, ...
HD-MTX has been widely used as a key element in treating various cancer types. In childhood malignancies, this agent has been added to standard chemotherapeutic regimens for ALL, NHL, and osteosarcoma ...
Haemonetics received clearance from the Food and Drug Administration for its next-generation plasma collection system. The medical technology company said Monday that the FDA granted 510(k) clearance ...
BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results